Clinical Trial Update: Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) [Phase 4]

View source ↗

Summary

Phase 4 trial (J-PREDICT) evaluated whether pitavastatin can prevent diabetes in people with impaired glucose tolerance; the study status is Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Prediabetes

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Tokyo University | Conditions: Diabetes Mellitus, Glucose Intolerance | Phase 4 | Status: COMPLETED